Expression Therapeutics is committed to advancing novel hemophilia therapeutics and improving global hemophilia care. In order to better accomplish our mission, we are always interested in exploring new funding and strategic partnering opportunities as well as targeted research collaborations.
For additional information please contact:
Partnering/investment opportunities – Dr. Mohan Rao, (312) 493-1928,
Technology inquiries – Dr. Christopher Doering, (678) 772-0751,
Other information – Dr. Gabriela Denning, (678) 892-8680,